Speaker Details

Jason Ezra Hawkes, MD, MS, FAAD

Jason Ezra Hawkes, MD, MS, FAAD

Oregon Medical Research Center

BIOGRAPHY

Dr. Hawkes is a board-certified dermatologist in Portland, Oregon. He is Co-Owner, Chief Scientific Officer, and Investigator at the Oregon Medical Research Center, as well as Clinical Assistant Professor of Dermatology at Oregon Health & Science University. He completed medical school and residency training at the University of Utah and completed a prestigious one-year immunology fellowship in the NIH-HHMI Research Scholars Program. Following his residency, he earned a Master’s Degree in Clinical Investigation at Rockefeller University, where he was Chief Clinical Scholar and member of the Laboratory of Investigative Dermatology. Dr. Hawkes previously held academic appointments in at the University of Utah, Icahn School of Medicine at Mount Sinai, and UC-Davis. His primary clinical and research interests include novel topical and systemic immune therapies for inflammatory conditions like psoriasis, atopic dermatitis, hidradenitis suppurativa, alopecia areata, vitiligo, and chronic urticaria. Dr. Hawkes also serves on several national and international steering committees or workgroups. He is the Deputy Chair for the Council on Education for the American Academy of Dermatology (AAD) and served as their official delegate for the revised international urticaria guidelines published in 2026. He also holds leadership positions in several patient advocacy groups, including serving as a Councilor for the International Psoriasis Council and member of the National Psoriasis Foundation’s Scientific Advisory Committee. From 2019-2025, Dr. Hawkes also served as a member of the NPF Medical Board.

SESSIONS

U002 Chronic Spontaneous Urticaria: A Review of the Basics and New and Emerging Drugs
Mar 19, 2027 • 7:30 AM - 8:30 AM
F052 Structure and Function of the Skin: Development, Cell Biology, and Skin Structure
Mar 21, 2027 • 1:00 PM - 3:00 PM

DISCLOSURES

AbbVie – Advisory Board(Fees), Investigator(Grants/Research Funding); Acelyrin – Investigator(Grants/Research Funding); Allakos – Investigator(Grants/Research Funding); Alumis – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Arcutis, Inc. – Advisory Board(Fees); Blueprint Medicines – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Celldex – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Incyte – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Kymera Therapeutics – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding), Speaker(Fees), Speaker(Honoraria); Novartis – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Speaker/Faculty Education(Honoraria); Organon – Advisory Board(Honoraria), Speaker(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Speaker(Honoraria), Stockholder(Stock); Sanofi Genzyme – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria);